EIM
AKYA

Essex Investment Management’s Akoya BioSciences AKYA Stock Holding History

Essex Investment Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-238,703
Closed -$1.95M – 372
2023
Q1 		$1.95M Buy
238,703
+107,715
+82% +$1.13M 0.28% 114
2022
Q4 		$1.25M Buy
+130,988
New +$1.61M 0.2% 160

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Essex Investment Management's AKYA Position: Q2 2023 in Review

Essex Investment Management sold out of Akoya BioSciences (AKYA) in Q2 2023, closing a stake of 238,703 shares — an estimated $1.95M sold.

Essex Investment Management first reported a position in AKYA in Q4 2022 and held it in 2 quarters. The position peaked at $1.95M in Q1 2023. 73 funds tracked by Wall St. Rank hold AKYA as of Q2 2023.

  • Essex Investment Management reported no remaining Akoya BioSciences position as of Q2 2023 after selling out during the quarter.
  • Essex Investment Management sold 238,703 Akoya BioSciences shares in Q2 2023, an estimated $1.95M.
  • Essex Investment Management first reported a position in Akoya BioSciences in Q4 2022 and held it in 2 quarters.
  • Essex Investment Management's Akoya BioSciences position peaked at $1.95M in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2023.

Based on Essex Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.